Mass balance and absolute bioavailability of avenciguat (14C) after intravenous or oral administration in healthy male participants.
Saved in:
| Title: | Mass balance and absolute bioavailability of avenciguat (14C) after intravenous or oral administration in healthy male participants. |
|---|---|
| Authors: | Joseph D; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Wong D; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Mitra P; Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Auclair AM; Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Wolfgang T; Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Gao E; Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Herich L; Clinical Statistics, Staburo GmbH, München, Germany., Tiessen R; Clinical Research Physician, ICON plc (Formerly PRA Health Sciences), Groningen, The Netherlands. |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2026 Jan; Vol. 35 (1), pp. 75-84. Date of Electronic Publication: 2026 Jan 13. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41489441 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mass balance and absolute bioavailability of avenciguat (<superscript>14</superscript>C) after intravenous or oral administration in healthy male participants. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Joseph+D%22">Joseph D</searchLink>; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.<br /><searchLink fieldCode="AU" term="%22Wong+D%22">Wong D</searchLink>; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.<br /><searchLink fieldCode="AU" term="%22Mitra+P%22">Mitra P</searchLink>; Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.<br /><searchLink fieldCode="AU" term="%22Auclair+AM%22">Auclair AM</searchLink>; Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.<br /><searchLink fieldCode="AU" term="%22Wolfgang+T%22">Wolfgang T</searchLink>; Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.<br /><searchLink fieldCode="AU" term="%22Gao+E%22">Gao E</searchLink>; Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.<br /><searchLink fieldCode="AU" term="%22Herich+L%22">Herich L</searchLink>; Clinical Statistics, Staburo GmbH, München, Germany.<br /><searchLink fieldCode="AU" term="%22Tiessen+R%22">Tiessen R</searchLink>; Clinical Research Physician, ICON plc (Formerly PRA Health Sciences), Groningen, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229434197%22">Expert opinion on investigational drugs</searchLink> [Expert Opin Investig Drugs] 2026 Jan; Vol. 35 (1), pp. 75-84. <i>Date of Electronic Publication: </i>2026 Jan 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9434197 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213543784%22">13543784 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Investig Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41489441 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/13543784.2025.2612329 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 75 Titles: – TitleFull: Mass balance and absolute bioavailability of avenciguat (14C) after intravenous or oral administration in healthy male participants. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Joseph D – PersonEntity: Name: NameFull: Wong D – PersonEntity: Name: NameFull: Mitra P – PersonEntity: Name: NameFull: Auclair AM – PersonEntity: Name: NameFull: Wolfgang T – PersonEntity: Name: NameFull: Gao E – PersonEntity: Name: NameFull: Herich L – PersonEntity: Name: NameFull: Tiessen R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1744-7658 Numbering: – Type: volume Value: 35 – Type: issue Value: 1 Titles: – TitleFull: Expert opinion on investigational drugs Type: main |
| ResultId | 1 |
